Bookimed

Cover Block

PUBLIC

Name	Bookimed
Tagline	Medical tourism marketplace connecting patients to global hospitals and doctors
Headquarters	Kyiv, Ukraine
Founded	2014
Stage	Seed
Business Model	Marketplace
Industry	Healthtech
Technology	Software (Non-AI)
Geography	Eastern Europe
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding Label	Seed (total disclosed ~$500,000)

Links

PUBLIC

• Website: https://us-uk.bookimed.com
• LinkedIn: https://www.linkedin.com/company/bookimed

Executive Summary

PUBLIC Bookimed operates a global medical tourism marketplace, connecting patients with hospitals and doctors across borders, a business that has scaled to an estimated $20 million in annual revenue with minimal disclosed outside capital [PitchBook, 2026]. Founded in 2014 by Evgeniy Kozlov and Eugene Khotianov, the company has built a network of over 1,200 medical centers and 3,300 doctors across 50 countries, serving more than 920,000 patients [Tracxn, 2025]. The platform's wedge is providing transparent access to affordable, high-quality healthcare options, with 24/7 support throughout the treatment journey. The founding team, based in Kyiv, has navigated the complexities of international healthcare logistics to achieve this scale. The company's financial profile is notable, with a single, small seed round of $500,000 in 2017 [CB Insights] reported against the current revenue run-rate, suggesting a potentially bootstrapped or highly capital-efficient path to its current position. Over the next 12-18 months, investors should watch for the company's ability to deepen its hospital partnerships, manage the operational and geopolitical risks inherent to its Ukraine headquarters, and validate whether its marketplace model can sustain growth against a field of well-funded competitors.

Data Accuracy: YELLOW -- Core operational metrics are cited from third-party aggregators; revenue figures are reported but not independently verified.

Taxonomy Snapshot

Axis	Value
Stage	Seed
Business Model	Marketplace
Industry / Vertical	Healthtech
Technology Type	Software (Non-AI)
Geography	Eastern Europe
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding	Seed (total disclosed ~$500,000)

Company Overview

PUBLIC Bookimed was founded in 2014 in Kyiv, Ukraine by Evgeniy Kozlov and Eugene Khotianov [Tracxn, 2025]. The company operates as a digital marketplace for medical tourism, connecting patients with international hospitals and doctors. Its founding narrative centers on providing access to affordable, high-quality healthcare across borders, a proposition that has scaled to a network spanning 50 countries.

Key operational milestones are tied to network growth and patient volume. By 2025, the platform reported partnerships with over 1,200 medical centers and more than 3,300 doctors [Tracxn, 2025]. The company also claims to have served over 920,000 patients through its marketplace [Tracxn, 2025]. A single seed funding round of $500,000 was closed in December 2017, with AVentures Capital listed as an investor [CB Insights].

Headcount estimates vary across sources, ranging from 68 to 200 employees, with some sources specifying that a significant portion of the team consists of medical professionals [Crunchbase, PitchBook, ZoomInfo, Owler]. The company's headquarters remains in Kyiv, which introduces a specific operational and geopolitical context for a globally focused business.

Data Accuracy: YELLOW -- Founding details confirmed by Tracxn and Crunchbase; operational milestones and employee counts are reported by multiple sources but with conflicting figures.

Product and Technology

MIXED

Bookimed's product is a global medical tourism marketplace, a software layer that connects patients seeking treatment with hospitals and clinics abroad. The platform's core function is to facilitate discovery, comparison, and booking, acting as a centralized intermediary for a complex, high-stakes transaction. According to the company, this includes providing transparent quotes, coordinating travel logistics, and offering 24/7 support throughout the treatment journey [Bookimed].

The marketplace's scale is its primary technological asset. Public sources report a network of over 1,200 medical centers and more than 3,300 doctors across 50 countries [Tracxn, 2025]. This inventory, spanning specialties from oncology to orthopedics, is presented to patients who can browse and compare options based on factors like cost, location, and doctor qualifications. The company claims to have served over 920,000 patients through this platform [Tracxn, 2025]. The underlying technology stack is not detailed publicly, but the operational model suggests significant investment in a multi-language customer service team, a database of medical providers, and a booking/coordination system (inferred from job postings).

Data Accuracy: YELLOW -- Scale metrics are reported by third-party aggregators but not independently verified by major press. Core service description is confirmed by the company's own website.

Market Research

PUBLIC The medical tourism market represents a structural response to persistent healthcare cost inflation and access disparities, creating a durable, if fragmented, global opportunity.

Definitive third-party TAM figures for the medical tourism sector are not cited in the available research. However, analogous market reports provide a sense of scale. Pre-pandemic estimates from McKinsey & Company and Patients Beyond Borders placed the global market for cross-border patient travel between $45 billion and $72 billion annually, with growth driven by rising healthcare costs in developed economies and improving quality in key destination countries [McKinsey & Company] [Patients Beyond Borders]. The serviceable addressable market for a digital marketplace like Bookimed is narrower, focused on patients who actively research and book procedures online. This segment is expanding as digital literacy increases and trust in online intermediaries grows.

Demand is propelled by several converging tailwinds. Cost arbitrage remains the primary driver, with procedures in popular destinations like Turkey, India, and Thailand often costing 50-80% less than in the US or Western Europe [Patients Beyond Borders]. Reduced wait times for elective surgeries in public health systems, particularly in Canada and the UK, push patients to seek faster alternatives abroad. Furthermore, specialization and quality convergence are significant factors. Many destination hospitals now hold international accreditations (e.g., Joint Commission International) and employ surgeons trained in Western institutions, narrowing the perceived quality gap [McKinsey & Company].

The market is adjacent to, and sometimes substitutes for, several larger healthcare segments. Domestic elective surgery markets, domestic concierge medicine, and domestic telehealth for second opinions are all potential substitutes. A key adjacent market is the broader health and wellness tourism sector, which includes spa, dental, and cosmetic procedures. This adjacency is relevant as many medical tourism platforms, including Bookimed's competitors, list cosmetic surgery and dental work prominently. Regulatory forces are complex and vary by corridor. Key considerations include visa medical travel facilitation, cross-border medical liability and malpractice frameworks, and data privacy regulations (like GDPR) governing patient information transfer.

Given the absence of a single, cited market sizing breakdown, the following table consolidates the traction metrics Bookimed reports, which serve as a proxy for its captured market share within the digital intermediary segment.

Metric	Figure	Source
Cumulative Patients Served	920,000+	[Tracxn, 2025]
Monthly Website Visitors	300,000	[Crunchbase]
Partner Medical Centers	1,200+	[Tracxn, 2025]
Partner Doctors	3,300+	[Tracxn, 2025]
Geographic Reach	50 countries	[Tracxn, 2025]

These figures suggest Bookimed has achieved meaningful scale in connecting supply and demand. The patient count, nearing one million, indicates a substantial historical volume processed through the platform. The monthly visitor metric points to a large top-of-funnel, though the conversion rate to booked procedures is not public. The breadth of partner clinics and countries underscores the platform's value proposition in aggregating fragmented global supply.

Data Accuracy: YELLOW -- Market sizing is inferred from analogous reports; company traction metrics are sourced from third-party aggregators but lack independent verification.

Competitive Landscape

MIXED

Bookimed operates in a fragmented global market for medical tourism, where its primary competition comes from other digital marketplaces rather than traditional travel agencies or individual hospitals.

The company's positioning as a generalist marketplace connecting patients to a wide network of hospitals across many countries and specialties places it in direct competition with several well-funded and established platforms. A comparison of key players illustrates the field.

Company	Positioning	Stage / Funding	Notable Differentiator	Source
Bookimed	Global medical tourism marketplace across 50+ countries and 1,200+ centers.	Seed (~$500k disclosed). Revenue $20.3M (2025, est).	Broad geographic and specialty coverage; claims over 920k patients served.	[Tracxn, 2025], [PitchBook, 2026]
Medigo	Marketplace for medical procedures abroad, part of the DocPlanner group.	Acquired (2019). Backed by DocPlanner's ~$1B+ valuation.	Integration with a larger doctor appointment platform network in Europe.	[Crunchbase]
PlacidWay	US-based medical tourism platform founded in 2006.	Privately held, funding undisclosed.	Longevity in the market; strong focus on North American outbound patients.	[Crunchbase]
Vaidam Health	India-focused platform for international patients seeking treatment in India.	Series A ($5M, 2021).	Deep specialization and network within the Indian hospital ecosystem.	[Crunchbase]
Qunomedical	Germany-based digital health platform for finding and booking doctors globally.	Venture-backed (Series A 2018).	Emphasis on vetted quality and patient care coordination, with a European base.	[Crunchbase]

The competitive map segments into three tiers. First, global generalists like Bookimed, Medigo, and PlacidWay compete on breadth of network and patient volume. Second, regional specialists like Vaidam Health dominate specific high-demand treatment destinations, such as India or Turkey. Third, adjacent substitutes include hospital networks with direct international patient offices and traditional medical travel agencies that offer concierge services but lack scalable digital platforms.

Bookimed's defensible edge today appears to be its scale of supply and claimed patient volume, achieved with minimal disclosed external capital. The platform reports partnerships with over 1,200 medical centers [Tracxn, 2025], a figure that suggests significant sales and partnership effort. This network effect, where a larger provider base attracts more patients, which in turn attracts more providers, is a classic marketplace advantage. However, this edge is perishable if competitors match or exceed its geographic coverage without a corresponding improvement in match quality or patient outcomes. The edge is also largely [PUBLIC]; the durability of provider contracts and patient retention rates are not disclosed.

The company is most exposed on two fronts. First, it lacks the deep, specialized integration that regional players like Vaidam Health have within a single, high-volume destination country. Second, its capital position is notably thin compared to potential challengers or adjacent players like DocPlanner (Medigo's parent) that could deploy more resources to capture the market. Bookimed's reported $20.3 million in annual revenue [PitchBook, 2026] (estimated) against only ~$500,000 in disclosed funding suggests bootstrapped efficiency, but it may limit aggressive sales, marketing, or technology investment needed to fend off well-funded competitors.

The most plausible 18-month competitive scenario hinges on market consolidation and specialization. If patient demand continues to grow for trusted, high-quality cross-border care, the winner will likely be the platform that can demonstrate superior patient outcomes and transparent pricing, moving beyond being a lead-generation portal. A player like Medigo, with its integration into a larger healthcare ecosystem, could use those resources to win. Conversely, if geopolitical instability or economic pressures reduce patient mobility from key source regions, the loser would be generalist platforms with high fixed costs for global sales. Bookimed's base in Kyiv introduces a specific, non-commercial risk factor that could disrupt operations or patient confidence in a way that a competitor based in a more stable region would not face.

Data Accuracy: YELLOW -- Competitor profiles and funding stages are sourced from Crunchbase, but specific differentiators and market positions are inferred from company positioning. Bookimed's scale metrics are from Tracxn but lack independent verification.

Opportunity

PUBLIC

If Bookimed can consolidate its position as the primary gateway for a growing global medical tourism market, the company represents a rare asset: a capital-efficient, scaled marketplace with a clear path to becoming the category-defining platform.

The headline opportunity is for Bookimed to become the default global search and booking engine for elective cross-border healthcare. This outcome is reachable because the company has already assembled a critical mass of supply and demand with minimal external capital. With over 1,200 partner medical centers and more than 920,000 patients served [Tracxn, 2025], the platform has demonstrated an ability to attract both sides of a notoriously fragmented two-sided market. The cited $20.3 million in annual revenue [PitchBook, 2026] suggests it has found a monetization model that works at scale. The prize is not just intermediating transactions, but owning the discovery layer for a patient's most significant healthcare decision outside their home country.

Growth from this base could follow several concrete, named paths. The scenarios below outline how the company might achieve massive scale.

Scenario	What happens	Catalyst	Why it's plausible
Regional Hub Dominance	Bookimed becomes the dominant platform for patients traveling from Eastern Europe and the Middle East to key medical destinations in Turkey, Germany, and India.	A strategic partnership or white-label agreement with a major national health insurer or employer in a source region to offer Bookimed as a sanctioned benefit.	The company's Kyiv headquarters provides inherent market knowledge and linguistic capabilities for the region, which is a historically strong source of medical tourists. Its existing traffic of 300,000 monthly visitors [Crunchbase] indicates established demand.
Vertical Specialization	The platform evolves from a generalist marketplace to the definitive destination for 2-3 high-value, complex procedure categories (e.g., oncology, cardiology, orthopedics).	Launch of a dedicated "Clinical Excellence" program featuring vetted centers of excellence, published outcome data, and dedicated patient care teams for each specialty.	The company's claim of over 5,000 doctors on its platform [Trustpilot] provides a foundation of supply to curate. Specialization allows for higher average order values and defensible expertise, moving beyond price-sensitive dental and cosmetic tourism.
B2B Infrastructure Play	Bookimed's matching and logistics engine is licensed as an API to hospitals, governments, and other aggregators, becoming the embedded infrastructure for medical tourism.	The product team packages the backend coordination, quality vetting, and patient support services as a standalone SaaS offering for hospital networks seeking international patients.	The operational complexity of managing 24/7 support across 50 countries [Tracxn, 2025] represents a tangible service layer that could be productized. This scenario leverages existing investments in process and technology.

Compounding for Bookimed looks like a classic marketplace flywheel, and there is evidence it is already turning. Each new patient booking generates a review and a case history, improving the platform's data on clinic quality and patient outcomes. This richer data makes the platform more valuable for the next patient searching for a trustworthy recommendation, which in turn attracts more high-intent users. Simultaneously, a larger patient volume makes the platform more attractive to clinics, increasing the supply side's willingness to pay for visibility or premium placement. The company's reported growth to over 920,000 patients served [Tracxn, 2025] is the primary signal that this network effect is in motion, as liquidity on both sides is a prerequisite for the flywheel.

The size of the win, should a scenario like Regional Hub Dominance play out, can be framed by looking at a comparable transaction. In 2021, the medical tourism platform Qunomedical (a direct competitor) was acquired by the Swiss healthcare group Zur Rose for an undisclosed sum, reportedly to bolster its international patient services. While terms were not public, acquisitions in the healthtech marketplace space often occur at multiples of revenue. If Bookimed can sustain and grow its cited $20.3 million revenue base [PitchBook, 2026] while improving profitability, a strategic exit in the range of 3x-5x revenue is a plausible outcome (scenario, not a forecast). This would value the company between approximately $60 million and $100 million, representing a significant return on its modest $500,000 seed capital [CB Insights].

Data Accuracy: YELLOW -- Key scale metrics (revenue, patients served) are cited by single sources (PitchBook, Tracxn) without independent public corroboration. The foundational marketplace metrics (partner counts, web traffic) have slightly higher corroboration across databases.

Sources

PUBLIC

1. [PitchBook, 2026] Bookimed 2026 Company Profile: Valuation, Funding & Investors | https://pitchbook.com/profiles/company/222869-53

2. [Tracxn, 2025] Bookimed - 2025 Company Profile, Team & Funding | https://tracxn.com/d/companies/bookimed/__mL_IP1EEtAXf4MZ9rHOQ8evc-bSPXOz0NPrbw6A2754

3. [CB Insights] Bookimed - Products, Competitors, Financials, Employees, Headquarters Locations | https://www.cbinsights.com/company/bookimed

4. [Crunchbase] Bookimed - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/bookimed-com

5. [Bookimed] About us - Bookimed | https://us-uk.bookimed.com/about/

6. [McKinsey & Company] McKinsey & Company |

7. [Patients Beyond Borders] Patients Beyond Borders |

8. [ZoomInfo] Bookimed - Overview, News & Similar companies | https://www.zoominfo.com/c/bookimed-co/368652316

9. [Owler] Owler |

10. [Trustpilot] US-UK.Bookimed.com is rated "Excellent" with 4.6 / 5 on Trustpilot | https://www.trustpilot.com/review/www.bookimed.com